Search for Clinical Trial Results

Mucopolysaccharidosis I - 57 Studies Found
Status | Study |
Completed |
Study Name: A Study to Evaluate the Safety, Tolerability and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA Condition: MPS IV A Date: 2009-04-10 Interventions: Drug: BMN 110 Subjects will receive a weekly 4- to 5-hour |
Enrolling by invitation |
Study Name: BMN 110 Phase 3B in Australian Patients Condition: Mucopolysaccharidosis IVA (Morquio A Syndrome) Date: 2013-09-10 Interventions: Drug: BMN 110 All pateints receive treatment with BMN 110 |
Terminated |
Study Name: Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation Condition:
Date: 2012-09-17 Interventions: Drug: BMN 110 Drug will be delivered through a 4 hour (approximate) IV infusion at a dosage amount of 2. |
Terminated |
Study Name: Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome Condition:
Date: 2012-05-24 Interventions: |
Completed |
Study Name: Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome) Condition:
Date: 2011-12-22 Interventions: Drug: BMN 110 Patients will receive intravenous (IV) infusions of study drug at a dose of 2.0 mg/kg/wk o |
Completed |
Study Name: ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I Condition: Mucopolysaccharidosis IH/S Date: 2025-08-05 Interventions: Autologous plasmablasts (B cells) engineered to express ?-L-iduronidase (IDUA) using the Sleeping Beauty (SB) transposon system. |
COMPLETED |
Study Name: A Natural History Study of Biomarkers and Clinical Outcomes in Mucopolysaccharidosis Type IIIA (MPS IIIA; Sanfilippo Syndrome) Condition: Mucopolysaccharidosis III-A Date: 2025-08-05 Interventions: No intervention |